Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 27.7 | 20.2 | 14.9 |
| Revenue growth | 37.3% | 35.2% | |
| Cost of goods sold | 10.9 | 9.9 | 7.1 |
| Gross profit | 16.8 | 10.3 | 7.8 |
| Gross margin | 60.7% | 51.1% | 52.1% |
| Selling, general and administrative | 26.0 | 19.0 | 12.6 |
| Research and development | 12.0 | 10.3 | 10.0 |
| EBIT | -21.2 | -19.0 | -14.9 |
| EBIT margin | -76.8% | -94.1% | -100.1% |
| Pre-tax income | -25.1 | -21.3 | -16.4 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -25.1 | -21.3 | -16.4 |
| Net margin | -90.8% | -105.6% | -109.8% |
| |
| Diluted EPS | ($17.97) | ($16.12) | ($14.50) |
| Shares outstanding (diluted) | 1.4 | 1.3 | 1.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|